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Background:

Head and neck cancers account for nearly 4% of
all cancers in the United States. The staging of
these cancers is important for physicians to
analyze and treat the patients. Furthermore, the
American Joint Committee on Cancer provides a
comprehensive framework to guide physicians on
staging these cancers. This study explores both
the staging of Oral Cavity and Oropharyngeal
cancers, as well as the AJCC editions utilized
between three Oncology specialties--Head and
Neck Surgery, Medical Oncology, and Radiology
Oncology.

a.

Methods:

A cohort of 100 Head and Neck cancer patients
with either Oral Cavity or Oropharyngeal
cancers were extracted from the EPIC
electronic medical records system. The tumor
stages and the edition of AJCC (7th edition or
8th edition) utilized by the three specialties.
The analysis is still ongoing. Furthermore, the
effect of the AJCC staging criteria on survival
was determined.

b.
Figure 3abc. These survival curce graphs allow us
to visualize the rate over survival over time when staged
with 7th versus the 8th edition of AJCC. Figura a. Shows
the survival rate for Medical Oncology tumor staging.
Figure b. Shows the survival rate for the Head
and Neck Surgeon tumor staging. Figure c. Shows
the survival rate for the Radiology Oncologist
tumor staging.

Conclusions:

c.

Results:

Table 1. The percentage of the number of times the three oncology
specialties list the type of edition used on the patient records.

Table 2: The amount of head and neck cancer patients' staged by
the three types of oncology specialties.

This work demonstrates the
frequency of the staging data
inputted by the physicians.
Ongoing efforts to assess the
survival of the patients
diagnosed with the 7th
versus 8th edition AJCC are
underway. The long-term
goal of this work is to create
an automated method for
oncologists across specialties
to consistently stage head
and neck cancers. A few of
the limitations of our study
include our small sample
size, as we utilized a cohort
of 100 patients. Another was
that not all of the physicians
documented which AJCC
edition they used for staging.
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Figure 1. This graph shows the amount times each oncology specialty annotated the
edition for each patient’s first visit.

Figure 2. This graph shows the result of the T stages mentioned by
the three oncology specialties.
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